Venus-Bad-2A-pEGFP-C1 Citations (1)
Originally described in: Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2.Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW Elife. 2019 Mar 12;8. pii: 37689. doi: 10.7554/eLife.37689. PubMed Journal
Articles Citing Venus-Bad-2A-pEGFP-C1
Articles |
---|
Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells.
Osterlund EJ, Hirmiz N, Pemberton JM, Nougarede A, Liu Q, Leber B, Fang Q, Andrews DW.
Sci Adv. 2022 Apr 22;8(16):eabm7375. doi: 10.1126/sciadv.abm7375. Epub 2022 Apr 20.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.